Medpace Holdings (MEDP) Gross Margin (2015 - 2026)

Medpace Holdings (MEDP) has reported Gross Margin for 12 consecutive years, with 27.78% the latest figure, recorded in Q1 2026.

• Gross Margin for Q1 2026 came in at 27.78%, down 415.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 29.07% (down 244.0% YoY), and the FY2025 annual result was 30.06%, down 106.0% from the prior year.
• Gross Margin was 27.78% for Q1 2026 at Medpace Holdings, down from 28.98% in the prior quarter.
• Over five years, Gross Margin peaked at 33.23% in Q4 2024 and troughed at 26.97% in Q2 2023.
• Average Gross Margin over 5 years is 29.57%, with a median of 29.82% recorded in 2022.
• Year-over-year, Gross Margin surged 578 bps in 2024 and sank 425 bps in 2025.
• Over 5 years, Gross Margin stood at 29.37% in 2022, then declined by 7 bps to 27.45% in 2023, then grew by 21 bps to 33.23% in 2024, then decreased by 13 bps to 28.98% in 2025, then dropped by 4 bps to 27.78% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 27.78% in Q1 2026, 28.98% in Q4 2025, and 29.84% in Q3 2025.